1 Saichan X,Wei C,Qinglong F,et al. Plasma cortisol as a noninvasive biomarker to assess severity and prognosis of patients with craniocerebral injury[J]. Eur Rev Med Pharmacol Sci,2016,20(18):3835-3838. 2 杜春亮,李娜,白西民,等. 丹参川芎嗪注射液辅治急性颅脑损伤患者的疗效及对血清HMGB1、NO、Fas水平的影响[J]. 疑难病杂志,2016,15(9):916-918. 3 Kasprowicz M,Burzynska M,Melcer T,et al. A comparison of the Full Outline of UnResponsiveness (FOUR) score and Glasgow Coma Score (GCS) in predictive modelling in traumatic brain injury[J]. British Journal of Neurosurgery,2016,30(2):211-215. 4 Ryan H M,Sharma S,Magee L A,et al. The Usefulness of the APACHE II Score in Obstetric Critical Care: A Structured Review[J]. Journal of Obstetrics & Gynaecology Canada,2016,38(10):909-918. 5 卢刚,黄礼明,王卫余,等. 2969例急性颅脑损伤患者的诊治分析[J]. 中华急诊医学杂志,2004,13(8):553-554. 6 戴守勇,沙龙贵. 早期钻孔引流术对高血压脑出血患者术区脑水肿面积的影响[J]. 医学临床研究,2018,35(2):375-377. 7 Nieder C,Mannsåker B,Dalhaug A,et al. The Glasgow prognostic score:Useful information when prescribing palliative radiotherapy[J]. Molecular & Clinical Oncology,2017,6(6):811-816. 8 刘强,韩如泉. 亚低温治疗在神经系统疾病和心脏骤停复苏中的应用[J]. 临床麻醉学杂志,2017,33(7):717-719. 9 孙国会,王保刚. 丹参川芎嗪注射液联合依达拉奉治疗颅脑损伤术后脑缺血[J]. 中国民间疗法,2014,22(1):55. 10 赵晓君,武晓瑛,刘晓斌,等. 川芎嗪注射液联合醒脑静注射液对重型颅脑损伤患者急性期脑血管痉挛的影响[J]. 现代中西医结合杂志,2016,25(22):2444-2446. 11 范文慧,裘五四. 丹参川芎嗪注射液对急性颅脑损伤患者炎症因子的影响[J]. 中国临床药理学杂志,2017,33(12):1082-1084. 12 徐春林,熊学辉,吴雅兰,等. 丹参川芎嗪联合长春西汀治疗颅脑损伤后遗症的临床研究[J]. 湖南中医药大学学报,2017,37(8):910-912. 13 Brand A,Singer K,Koehl G E,et al. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells[J]. Cell Metabolism,2016,24(5):657-671. |